(Q40561425)

21 September 2017

title

Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. (English)

1 reference

21 September 2017

1 reference

acute myeloid leukemia

1 reference

R Tang

1

1 reference

21 September 2017

A-M Faussat

2

1 reference

21 September 2017

P Majdak

3

1 reference

21 September 2017

J-Y Perrot

4

1 reference

21 September 2017

D Chaoui

5

1 reference

21 September 2017

O Legrand

6

1 reference

21 September 2017

J-P Marie

7

1 reference

21 September 2017

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

18

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

1246-1251

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403390

21 September 2017

exact match

0 references

cites work

Cell biological mechanisms of multidrug resistance in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

P-glycoprotein--a mediator of multidrug resistance in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Induction of Apoptosis in BCR/ABL+ Cells By Histone Deacetylase Inhibitors Involves Reciprocal Effects on the RAF/MEK/ERK and JNK Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403390

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403390

1 reference

Dimensions Publication ID

21 September 2017

1016032644

0 references

1 reference